
==== Front
ACS OmegaACS OmegaaoacsodfACS Omega2470-1343American Chemical Society 3145896110.1021/acsomega.8b00855ArticleCopper-Catalyzed Benign and Efficient Oxidation of
Tetrahydroisoquinolines and Dihydroisoquinolines Using Air as a Clean
Oxidant Zheng Bo †‡Trieu Tien Ha ‡Li Feng-Lei ‡Zhu Xing-Liang ‡He Yun-Gang ‡Fan Qi-Qi ‡Shi Xiao-Xin *†‡†Shanghai
Key Laboratory of Chemical Biology, School of Pharmacy, and ‡Department of
Pharmaceutical Engineering, School of Pharmacy, East China University of Science and Technology, 130 Mei-Long Road, Shanghai 200237, P. R. China* E-mail: xxshi@ecust.edu.cn (X.-X.S.).24 07 2018 31 07 2018 3 7 8243 8252 29 04 2018 06 06 2018 Copyright © 2018 American Chemical Society2018American Chemical SocietyThis is an open access article published under an ACS AuthorChoice License, which permits copying and redistribution of the article or any adaptations for non-commercial purposes.

A green
chemical method for mild oxidation of 1,2,3,4-tetrahydroisoquinolines
(THIQs) and 3,4-dihydroisoquinolines (DHIQs) has been developed using
air (O2) as a clean oxidant. DHIQs and THIQs could be efficiently
oxidized to isoquinolines in dimethyl sulfoxide at 25 °C under
an open air atmosphere with CuBr2 (20 mol %) as the catalyst;
different bases [NaOEt and/or 1,8-diazabicyclo[5,4,0]undec-7-ene]
were used for the reaction according to the patterns of substituents
(R1, R2).

document-id-old-9ao8b00855document-id-new-14ao-2018-00855dccc-price
==== Body
1 Introduction
Isoquinolines
are a very important kind of compounds because of
the following reasons. First, isoquinoline alkaloids are widely spread
in nature and have been isolated from many natural resources.1 Second, isoquinoline alkaloids and their synthetic
congeners have shown a broad spectrum of bioactivities.2 Third, isoquinolines have been used as versatile
intermediates in comprehensive organic transformations.3 Fourth, chiral isoquinoline ligands and N-oxides
have been successfully used in asymmetric catalysis.4 Fifth, isoquinolines or their metal complexes have also
been used as various functional materials.5 In view of the abovementioned wide utilities of isoquinolines in
drug discovery, organic chemistry, and material science, development
of new methods for the synthesis of isoquinolines is of considerable
interest and has already attracted much attention from many chemists
in the recent years.6

Because 1,2,3,4-tetrahydroisoquinolines
(THIQs) and 3,4-dihydroisoquinolines
(DHIQs) can be readily prepared via Pictet–Spengler reaction7 or Bischler–Napieralski cyclization,8 dehydrogenation or oxidation of THIQs and DHIQs
might be good approaches for the synthesis of isoquinolines. However,
dehydrogenation of THIQs/DHIQs usually needed precious metallic catalysts
(Pd, Ru, Ir, etc.) and higher temperature;9 oxidation of THIQs/DHIQs often suffered from the use of poisonous
and hazardous strong oxidants such as KMnO4,10 IBX,11 PCC,12 (KSO3)2NO,5f,13 NaIO4,14 V2O5,15 MnO2,16 and PhSSPh.17 To
overcome these drawbacks, development of an efficient, mild, and eco-friendly
method for the conversion of THIQs and DHIQs to isoquinolines is highly
desirable and remains to be a challenging task for organic chemists.

Copper is a cost-effective transition metal with low toxicity,
and air (O2) is an eco-friendly clean oxidant. Hence, increasing
amounts of copper-catalyzed aerobic oxidation methods for various
compounds have been recently developed.18 Herein, we report an efficient, practical, and very mild method
for copper-catalyzed oxidation of THIQs and DHIQs using air (O2) as the clean oxidant.

2 Results
and Discussion
At first, we attempted to find out the optimized
reactions for
the Cu-catalyzed oxidative conversion of THIQs to isoquinolines. With
the oxidative conversion of 1-phenyl-6,7-dimethoxy-THIQ 1a to 1-phenyl-6,7-dimethoxy-DHIQ 2a and 1-phenyl-6,7-dimethoxyisoquinoline 3a as the model reaction, we tried the reaction under various
conditions, and the results are summarized in Table 1. As can be seen from Table 1, a copper catalyst was necessary for the
reaction, otherwise no reaction occurred (Table 1, entry 1). When 20 mol % of CuBr2 was used as the catalyst and 1,8-diazabicyclo[5,4,0]undec-7-ene
(DBU) was used as the base, the reaction occurred in dimethyl sulfoxide
(DMSO) to produce DHIQ 2a in high yield, but only trace
amount of desired isoquinoline 3a was detected (entries
2 and 3). If a strong base such as NaOEt or NaOMe was further added,
the reaction took place smoothly at 25 °C to afford the desired
isoquinoline 3a in high yield (Table 1, entries 4 and 5). Other copper salts including
CuCl2, Cu(OAc)2, CuCl, CuBr, CuSO4, and Cu2(OH)2CO3 have also been
tested as a catalyst (entries 6–11), and it was found that
CuBr2 is the best catalyst for the reaction. Other amines
such as 1,5-diazabicyclo[4,3,0]non-5-ene (DBN), 4-dimethylaminopyridine
(DMAP), pyridine, and Et3N have been tested as the base
(entries 12–15) for the first step (from 1a to 2a), and it was found that DBU worked better than the other
amines. A very strong base (NaOMe or NaOEt) seems to be necessary
for the second step (from 2a to 3a) because
weak bases almost did not work (see Table 1, entries 3, 17 and 18). Several other solvents
such as N,N-dimethylformamide (DMF),
acetonitrile, ethanol, tetrahydrofuran, and 1,2-dimethoxyethane (DME)
have also been tested as the solvent for the reaction (entries 19–23),
and it was observed that DMSO is the most appropriate solvent here.
If less than 2.0 equiv of bases was used, the reaction became slower.
When the reaction temperature was increased (35–80 °C),
the yield of the desired product 3a decreased significantly
(see Table 1, entries
24–28).

Table 1 Optimization of Reaction Conditions
for the Cu-Catalyzed Aerobic Oxidative Conversion of 1-Phenyl-6,7-dimethoxy-THIQ 1a to 1-Phenyl-6,7-dimethoxyisoquinoline 3aa
entry	catalystb	base-1/base-2 (equiv)	solvent	T (°C)	t1/t2 (h)	yields (%)c (2a/3a)	
1	none	DBUd(2.0)/NaOEt(2.0)	DMSOe	25	10/8	0/0	
2	CuBr2	DBU(2.0)/none	DMSO	25	10/0	93/<1	
3	CuBr2	DBU(2.0)/DBU(2.0)	DMSO	25	10/10	93/<1	
4	CuBr2	DBU(2.0)/NaOEt(2.0)	DMSO	25	10/8	0/95	
5	CuBr2	DBU(2.0)/NaOMe(2.0)	DMSO	25	10/8	0/90	
6	CuCl2	DBU(2.0)/NaOEt(2.0)	DMSO	25	10/8	0/92	
7	Cu(OAc)2	DBU(2.0)/NaOEt(2.0)	DMSO	25	10/8	0/88	
8	CuBr	DBU(2.0)/NaOEt(2.0)	DMSO	25	10/8	0/86	
9	CuCl	DBU(2.0)/NaOEt(2.0)	DMSO	25	10/8	0/85	
10	CuSO4	DBU(2.0)/NaOEt(2.0)	DMSO	25	10/8	3/15f	
11	Cu2(OH)2CO3	DBU(2.0)/NaOEt(2.0)	DMSO	25	10/8	2/10f	
12	CuBr2	DBNg(2.0)/NaOEt(2.0)	DMSO	25	10/8	0/89	
13	CuBr2	DMAPh(2.0)/NaOEt(2.0)	DMSO	25	10/8	5/65f	
14	CuBr2	Py(2.0)/NaOEt(2.0)	DMSO	25	10/8	7/57f	
15	CuBr2	Et3N(2.0)/NaOEt(2.0)	DMSO	25	10/8	8/45f	
16	CuBr2	none	DMSO	25	25/0	5/0f	
17	CuBr2	DBU(2.0)/K2CO3(2.0)	DMSO	25	10/12	92/<1	
18	CuBr2	DBU(2.0)/Na2CO3(2.0)	DMSO	25	10/12	91/<1	
19	CuBr2	DBU(2.0)/NaOEt(2.0)	DMFi	25	10/10	5/78f	
20	CuBr2	DBU(2.0)/NaOEt(2.0)	CH3CN	25	10/10	6/36f	
21	CuBr2	DBU(2.0)/NaOEt(2.0)	EtOH	25	10/10	7/23f	
22	CuBr2	DBU(2.0)/NaOEt(2.0)	THFj	25	10/10	5/27f	
23	CuBr2	DBU(2.0)/NaOEt(2.0)	DMEk	25	10/10	9/35f	
24	CuBr2	DBU(1.0)/NaOEt(1.0)	DMSO	35	15/15	0/91	
25	CuBr2	DBU(1.0)/NaOEt(1.0)	DMSO	45	12/12	0/84	
26	CuBr2	DBU(1.0)/NaOEt(1.0)	DMSO	65	10/10	0/82	
27	CuBr2	DBU(0.5)/NaOEt(1.0)	DMSO	65	15/10	0/80	
28	CuBr2	DBU(0.5)/NaOEt(0.5)	DMSO	80	12/12	0/72	
a The standard procedure: THIQ 1a (2
mmol), Cu-catalyst (0.4 mmol), solvent (6 mL), and base-1
for t1 hours and then base-2 for t2 hours at T °C under
air (O2).

b 20
mol % of the catalyst was used.

c Isolated yields unless otherwise
indicated.

d DBU = 1,8-diazabicyclo[5,4,0]undec-7-ene.

e DMSO = dimethyl sulfoxide.

f The yields were determined
by gas
chromatography–mass spectrometry.

g DBN = 1,5-diazabicyclo[4,3,0]non-5-ene.

h DMAP = 4-dimthylaminopyridine.

i DMF = N,N-dimethyl-foramide.

j THF = tetrahydrofuran.

k DME = 1,2-dimethoxyethane.

Next, to know the scope of the reaction, we have attempted Cu-catalyzed
aerobic oxidation of variously substituted THIQs 1, which
were prepared from corresponding amines and aldehydes via Pictet–Spengler
reaction. A total of 25 THIQs 1a–y have been tested
for the reaction using either method A or method B (see footnote of Table 2), and the results
are summarized in Table 2. As can be seen from the Table 2, the scope of the reaction is wide; it could be applicable
to substrates with various substituents to afford the desired isoquinolines 3a–y in high yields. CuBr2 (20 mol %) was
used as the catalyst and DMSO was used as the solvent in all cases.
Method A and method B were used for different types of THIQs 1 according to the different patterns of substituents (R1 and R2). When method A was used for CuBr2-catalyzed oxidation of THIQs 1a–l, the desired
isoquinolines 3a–l could be obtained in high yields.
If method B was used for CuBr2-catalyzed oxidation of THIQs 1a–l, intermediate compounds DHIQs 2a–l were obtained as the major product and the further oxidation of
these intermediate compounds 2a–l to isoquinolines 3a–l was sluggish even at an elevated temperature (45–80
°C). When method B was used for CuBr2-catalyzed oxidation
of THIQs 1m–y, the reaction took place smoothly
to afford isoquinolines 3m–y in high yields. It
was observed that the presence of electron-withdrawing ester groups
(CO2Me or CO2Et) at C-1 or C-3 positions of
THIQs 1m–1y has almost no effect on the first
step (from 1m–y to 2m–y) of
the reaction but it could dramatically speed up the second step (from 2m–y to 3m–y) of the reaction.
Notably, only trace amounts of intermediate compounds 2m–y were detected by careful thin-layer chromatography (TLC) analysis
during the CuBr2-catalyzed oxidative conversion of THIQs 1m–y to isoquinolines 3m–y.

Table 2 CuBr2-Catalyzed Oxidative
Conversion of Variously Substituted THIQs 1 To Isoquinolines 3a
a Method A: THIQs 1 (2
mmol), CuBr2 (0.4 mmol), DMSO (6 mL), and DBU (4 mmol)
at 25 °C (inner temperature) under air (O2) for t1 h and then NaOEt (4 mmol) at 25 °C under
air (O2) for t2 h; method B:
THIQs 1 (2 mmol), CuBr2 (0.4 mmol), DMSO (6
mL), and DBU (4 mmol) at 25 °C under air (O2) for t h.

b Isolated
yields.

c Method A was used
for isoquinolines 3a–l.

d Method B was used for isoquinolines 3m–y.

Subsequently, we attempted
Cu-catalyzed aerobic oxidation of variously
substituted DHIQs 2, which were prepared from corresponding
amides via Bischler–Napieralski cyclization. A total of 15
DHIQs 2 have been tested for the reaction using either
method C or method D (see footnote of Table 3), and the results are summarized in Table 3. As can be seen from
the Table 3, CuBr2 (20 mol %) was used as the catalyst and DMSO was used as
the solvent in all cases. Method C and method D were used for different
types of DHIQs 2 according to the different patterns
of substituents (R1 and R2). Method C (with
a strong base) was used for CuBr2-catalyzed oxidation of
DHIQs 2a–d, 2g, 2h,
and 2j, which do not contain an electron-withdrawing
group; method D (with a weak base) was used for CuBr2-catalyzed
oxidation of DHIQs 2m, 2n, 2q, 2t, 2u, 2v, 2x, and 2y, which contain an electron-withdrawing group
at C-1 or C-3. The desired isoquinolines 3 could be obtained
in high yields in all cases.

Table 3 CuBr2-Catalyzed
Oxidative
Conversion of Variously Substituted THIQs 2 To Isoquinolines 3a
a Method C: THIQs 1 (2
mmol), CuBr2 (0.4 mmol), DMSO (6 mL), and NaOEt (4 mmol)
at 25 °C under air (O2) for t h;
method D: THIQs 1 (2 mmol), CuBr2 (0.4 mmol),
DMSO (6 mL), and DBU (2 mmol) at 25 °C under air (O2) for t h.

b Isolated yields.

c Method
C was used for isoquinolines 3a–d, 3g, 3h, and 3j.

d Method D was used for isoquinolines 3m, 3n, 3q, 3t, 3u, 3v, 3x, and 3y.

A possible mechanism for the CuBr2-catalyzed oxidation
of THIQs 1 and DHIQs 2 to isoquinolines 3 was proposed in Scheme 1. As can be seen from Scheme 1, THIQs 1 would first undergo
CuBr2-catalyzed aerobic oxidation of C–N single
bond to C=N double bond to produce DHIQs 2 according
to Adimurthy’s reports.19 DHIQs 2 would then undergo base-promoted reversible tautomerization20 to form enamine intermediates I-A and I-B, which are unstable and would again immediately
undergo CuBr2-catalyzed aerobic oxidation of C–N
single bond to C=N double bond to afford isoquinolines 3. The presence of an ester group at the C-1 or/and C-3 positions
could promote the formation of enamine intermediates I-A and I-B and would thus allow the use of DBU (a relatively
weak base). Otherwise NaOEt (a strong base) should be used.

Scheme 1 Possible
Mechanism for the CuBr2-Catalyzed Oxidation of
THIQs 1 and DHIQs 2 To Isoquinolines 3
3 Conclusions
In conclusion, we have developed a novel practical method for copper-catalyzed
oxidation of THIQs 1 and DHIQs 2 to isoquinolines 3. In this green chemical method, CuBr2 (20 mol
%) was chosen as the catalyst, as it works better than other copper
salts; DMSO was selected as the solvent, as it is more appropriate
for the reaction than other solvents; and air (O2) was
used as a clean oxidant. The method has some advantages such as mildness
(25 °C), eco-friendliness, with good tolerance of functional
groups, ease of the experimental procedure, and high reaction yields.
This method might be more cost effective and practical than the known
dehydrogenation method9 which used precious
metallic catalysts. This method might also be more benign than the
classic known oxidation methods10−17 which used poisonous and hazardous strong oxidants. It would provide
a new general basic approach toward the syntheses of isoquinoline
alkaloids and their derivatives.

4 Experimental
Section
4.1 General Method
1H NMR
and 13C NMR spectra were acquired on a Bruker AM-400 instrument;
chemical shifts are given on the δ scale as parts per million
(ppm) with tetramethylsilane as the internal standard. IR spectra
were recorded with a Nicolet Magna IR-550 instrument. Mass spectra
were recorded with an HP1100 LC–MS spectrometer. Melting points
were determined on a Mel-Temp II apparatus. Column chromatography
was performed on silica gel (Qingdao Ocean Chemical Corp.). All chemicals
were analytically pure.

4.2 General Procedure for the
Preparation of THIQs 1(21)
2-Aryl ethanamine
(5.0 mmol) and aldehyde (6.0 mmol) were dissolved in a mixed solvent
of CHCl3 (4 mL) and trifluoroacetyl (4 mL). The resulting
solution was then heated and stirred at reflux for 6–10 h.
After the reaction was complete (checked by TLC, eluent: EtOAc/CH2Cl2 = 1:2), the solution was concentrated under
vacuum to dryness. The residue was then partitioned between ethyl
acetate (50 mL) and an aqueous solution of potassium carbonate (10
w/v %, 25 mL) and the aqueous was extracted again with ethyl acetate
(15 mL). The organic extracts were combined and washed twice with
brine (2 × 10 mL). After having been dried with anhydrous MgSO4, the organic solution was concentrated under vacuum to give
crude product, which was purified by flash chromatography (eluent:
CH2Cl2/CH3OH = 20:1–10:1)
to afford pure THIQs 1 (1a–y) in
65–92% yields.

4.3 General Procedure for the
Preparation of DHIQs 2(22)
N-Acyl-2-aryl-ethanamine (5.0 mmol) and POCl3 (10.0 mmol)
were dissolved in toluene (10 mL). The reaction mixture was then heated
and stirred at reflux for 5–12 h under an argon atmosphere.
After the reaction was complete (checked by TLC, eluent: EtOAc/hexane
= 1:2), the solution was concentrated under vacuum to dryness. The
residue was then partitioned between ethyl acetate (50 mL) and an
aqueous solution of potassium carbonate (15 w/v %, 35 mL) and the
aqueous was extracted again with ethyl acetate (25 mL). The organic
extracts were combined and washed twice with brine (2 × 10 mL).
After having been dried with anhydrous MgSO4, the organic
solution was concentrated under vacuum to give crude product, which
was purified by flash chromatography (eluent: CH2Cl2/EtOAc = 30:1–5:1) to afford pure DHIQs 2 (2a–d, 2g, 2h, 2j, 2m, 2n, 2q, 2t, 2u, 2v, 2x, and 2y) in 60–89% yields.

4.4 General
Procedure for the CuBr2-Catalyzed Conversion of THIQs 1 To Isoquinolines 3
4.4.1 Method
A
THIQ 1 (∼2.0
mmol) was dissolved in DMSO (6 mL). DBU (0.612 g, 4.020 mmol) and
CuBr2 (0.090 g, 0.403 mmol) were then added. The resulting
solution was stirred at 25 °C under an open air atmosphere for t1 h (see Table 2). When the starting compound almost disappeared (checked
by TLC, eluent: EtOAc/hexane = 1:2), EtONa (0.276 g, 4.056 mmol) was
added, and the reaction solution was further stirred at 25 °C
for t2 h (see Table 2). After the reaction was complete (checked
by TLC, eluent: EtOAc/hexane = 1:2), the reaction solution was poured
into the mixed solution of EtOAc (30 mL) and aqueous ammonia (5 w/w
%, 20 mL). After the mixture was stirred for 5 min, two phases were
separated. The aqueous layer was extracted again with EtOAc (20 mL).
The organic extracts were combined and washed with brine (15 mL).
The organic solution was dried over anhydrous MgSO4 and
then was concentrated under vacuum to give the crude product, which
was purified by flash chromatography (eluent: EtOAc/CH2Cl2 = 1:10–1:4) to afford isoquinolines 3a–l in the yields as indicated in Table 2.

4.4.2 Method B
THIQ 1 (∼2.0
mmol) was dissolved in DMSO (6 mL). DBU (0.612 g, 4.020 mmol) and
anhydrous CuBr2 (0.090 g, 0.403 mmol) were added. The resulting
solution was then stirred at 25 °C under an open air atmosphere
for t h (see Table 2). After the reaction was complete (checked by TLC,
eluent: EtOAc/hexane = 1:2), the reaction solution was poured into
the mixed solution of EtOAc (30 mL) and aqueous ammonia (5 w/w %,
20 mL). After the mixture was stirred for 5 min, two phases were separated.
The aqueous layer was extracted again with EtOAc (20 mL). The organic
extracts were combined and washed with brine (15 mL). The organic
solution was dried over anhydrous MgSO4 and then was concentrated
under vacuum to give the crude product, which was purified by flash
chromatography (eluent: EtOAc/CH2Cl2 = 1:10–1:4)
to afford isoquinolines 3m–y in the yields as
indicated in Table 2.

4.5 General Procedure for the CuBr2-Catalyzed Conversion of DHIQs 2 To Isoquinolines 3
4.5.1 Method C
DHIQ 1 (∼2.0
mmol) and anhydrous CuBr2 (0.090 g, 0.403 mmol) were dissolved
in DMSO (6 mL). EtONa (0.276 g, 4.056 mmol) was added. The resulting
solution was then stirred at 25 °C under an open air atmosphere
for t h (see Table 3). After the reaction was complete (checked by TLC,
eluent: EtOAc/hexane = 1:2), the reaction solution was poured into
the mixed solution of EtOAc (30 mL) and aqueous ammonia (5 w/w %,
20 mL). After the mixture was stirred for 5 min, two phases were separated.
The aqueous layer was extracted again with EtOAc (20 mL). The organic
extracts were combined and washed with brine (15 mL). The organic
solution was dried over anhydrous MgSO4 and then was concentrated
under vacuum to give the crude product, which was purified by flash
chromatography (eluent: EtOAc/CH2Cl2 = 1:10–1:4)
to afford isoquinolines 3a–d, 3g, 3h, and 3j in the yields as indicated in Table 3.

4.5.2 Method D
DHIQ 1 (∼2.0
mmol) and anhydrous CuBr2 (0.090 g, 0.403 mmol) were dissolved
in DMSO (6 mL). DBU (0.306 g, 2.010 mmol) was added. The resulting
solution was then stirred at 25 °C under an open air atmosphere
for t h (see Table 3). After the reaction was complete (checked by TLC,
eluent: EtOAc/hexane = 1:2), the reaction solution was poured into
the mixed solution of EtOAc (30 mL) and aqueous ammonia (5 w/w %,
20 mL). After the mixture was stirred for 5 min, two phases were separated.
The aqueous layer was extracted again with EtOAc (20 mL). The organic
extracts were combined and washed with brine (15 mL). The organic
solution was dried over anhydrous MgSO4 and then was concentrated
under vacuum to give the crude product, which was purified by flash
chromatography (eluent: EtOAc/CH2Cl2 = 1:10–1:4)
to afford isoquinolines 3m, 3n, 3q, 3t, 3u, 3v, 3x, and 3y in the yields as indicated in Table 3.

4.6 Characterization
Data of Isoquinolines 3a–y
4.6.1 6,7-Dimethoxy-1-phenylisoquinoline
(3a)
White crystals, mp 120–121 °C. 1H NMR (CDCl3, 400 MHz): δ 8.48 (d, J = 5.6 Hz, 1H), 7.71 (d, J = 7.3 Hz, 2H),
7.45–7.60 (m, 4H), 7.37 (s, 1H), 7.12 (s, 1H), 4.04 (s, 3H),
3.86 (s, 3H). 13C NMR (CDCl3, 100 MHz): δ
158.2, 152.7, 150.0, 141.3, 134.0, 133.8, 129.6 (2C), 128.5, 128.4
(2C), 122.5, 118.8, 105.6, 105.0, 56.1, 55.9. IR (KBr film): 2958,
2938, 1623, 1559, 1508, 1476, 1418, 1266, 1236, 1119, 1008, 847 cm–1. HRMS (ESI): calcd for C17H16NO2 [M + H]+, 266.1181; found, 266.1182.

4.6.2 1-(Benzo[d][1,3]dioxol-5-yl)-6,7-dimethoxyisoquinoline
(3b)
White crystals, mp 130–131 °C. 1H NMR (CDCl3, 400 MHz): δ 8.44 (d, J = 5.6 Hz, 1H), 7.48 (d, J = 5.6 Hz, 1H),
7.42 (s, 1H), 7.21 (s, 1H), 7.19 (d, J = 7.9 Hz,
1H), 7.12 (s, 1H), 6.97 (d, J = 7.9 Hz, 1H), 6.05
(s, 2H), 4.05 (s, 3H), 3.90 (s, 3H). 13C NMR (CDCl3, 100 MHz): δ 157.7, 152.6, 150.0, 147.9, 147.8, 141.2,
134.0, 133.8, 123.5, 122.5, 118.6, 110.2, 108.2, 105.5, 105.0, 101.3,
56.1, 55.9. IR (KBr film): 2960, 2922, 1623, 1558, 1509, 1482, 1445,
1241, 1039, 858 cm–1. HRMS (EI): calcd for C18H15NO4 [M]+, 309.1001; found,
309.1002.

4.6.3 1-(3,4-Dimethoxyphenyl)-6,7-dimethoxyisoquinoline
(3c)
White crystals, mp 150–151 °C. 1H NMR (CDCl3, 400 MHz): δ 8.47 (d, J = 5.6 Hz, 1H), 7.50 (d, J = 5.6 Hz, 1H),
7.45 (s, 1H), 7.29 (s, 1H), 7.28 (d, J = 7.9 Hz,
1H), 7.13 (s, 1H), 7.03 (d, J = 7.9 Hz, 1H), 4.05
(s, 3H), 3.98 (s, 3H), 3.95 (s, 3H), 3.89 (s, 3H). 13C
NMR (CDCl3, 100 MHz): δ 157.8, 152.5, 149.9, 149.2,
148.9, 141.1, 133.8, 132.6, 122.4, 122.2, 118.5, 112.8, 110.8, 105.6,
105.0, 56.0, 55.9 (2C), 55.8. IR (KBr film): 2933, 1516, 1422, 1259,
1244, 1167, 1030 cm–1. HRMS (EI): calcd for C19H19NO4 [M]+, 325.1314; found,
325.1312.

4.6.4 6,7-Dimethoxy-1-(thiophen-2-yl)isoquinoline
(3d)
White crystals, mp 119–120 °C. 1H NMR (CDCl3, 400 MHz): δ 8.43 (d, J = 5.6 Hz, 1H), 7.81 (s, 1H), 7.61 (d, J = 3.6 Hz, 1H), 7.52 (d, J = 5.1 Hz, 1H), 7.45 (d, J = 5.6 Hz, 1H), 7.22 (dd, J1 = 5.1 Hz, J2 = 3.6 Hz, 1H), 7.10 (s,
1H), 4.04 (s, 3H), 3.99 (s, 3H). 13C NMR (CDCl3, 100 MHz): δ 152.8, 151.0, 150.6, 143.3, 141.2, 134.1, 127.7,
127.6, 127.4, 122.1, 118.8, 105.2, 105.1, 56.1, 56.0. IR (KBr film):
2931, 1623, 1559, 1509, 1478, 1433, 1240, 1160, 1100, 863, 774 cm–1. HRMS (ESI): calcd for C15H14NO2S [M + H]+, 272.0745; found, 272.0744.

4.6.5 6,7-Dimethoxy-1-(4-fluorophenyl)isoquinoline
(3e)
White crystals, mp 125–126 °C. 1H NMR (DMSO-d6, 400 MHz): δ
8.45 (d, J = 5.5 Hz, 1H), 7.82 (dd, J1 = 8.6 Hz, J2 = 5.7 Hz, 2H),
7.73 (d, J = 5.5 Hz, 1H), 7.50 (s, 1H), 7.43 (dd, J1 = 8.9 Hz, J2 =
8.6 Hz, 2H), 7.33 (s, 1H), 4.01 (s, 3H), 3.84 (s, 3H). 13C NMR (DMSO-d6, 100 MHz): δ 163.3,
160.9, 156.0, 152.4, 149.9, 140.9, 136.1 (d, 4JCF = 3.0 Hz, 1C), 133.3, 131.7 (d, 3JCF = 8.1 Hz, 2C), 121.5, 118.9, 115.2 (d, 2JCF = 21.1 Hz, 2C), 105.0 (d, 1JCF = 102.6 Hz, 1C), 55.7, 55.2.
IR (KBr film): 2964, 1601, 1556, 1507, 1478, 1417, 1261, 1221, 1161,
1117, 839, 782, 570 cm–1. HRMS (ESI): calcd for
C17H15FNO2 [M + H]+, 284.1087;
found, 284.1085.

4.6.6 6,7-Dimethoxyisoquinoline
(3f)
White crystals, mp 91–92 °C. 1H
NMR (CDCl3, 400 MHz): δ 9.04 (s, 1H), 8.39 (d, J = 5.6 Hz, 1H), 7.50 (d, J = 5.6 Hz, 1H),
7.20 (s, 1H), 7.06 (s, 1H), 4.03 (s, 6H). 13C NMR (CDCl3, 100 MHz): δ 153.0, 150.3, 149.9, 142.0, 132.5, 124.8,
119.2, 105.3, 104.5, 56.1, 56.0. IR (KBr film): 2970, 2839, 1624,
1576, 1506, 1481, 1255, 1210, 1144, 1003, 858 cm–1. HRMS (EI): calcd for C11H11NO2 [M]+, 189.0790; found, 189.0795.

4.6.7 6,7-Dimethoxy-1-methylisoquinoline (3g)
White crystals, mp 104–105 °C. 1H NMR (CDCl3, 400 MHz): δ 8.25 (d, J = 6.2 Hz,
1H), 7.67 (d, J = 6.2 Hz, 1H),
7.35 (s, 1H), 7.20 (s, 1H), 4.11 (s, 3H), 4.10 (s, 3H), 3.17 (s, 3H). 13C NMR (CDCl3, 100 MHz): δ 156.4, 153.0,
151.7, 139.4, 132.1, 125.1, 121.9, 106.5, 104.0, 56.2, 56.1, 22.7.
IR (KBr film): 2960, 2935, 1621, 1570, 1508, 1482, 1440, 1424, 1278,
1235, 1206, 1160, 1060, 862 cm–1. HRMS (EI): calcd
for C12H13NO2 [M]+, 203.0946;
found, 205.0950.

4.6.8 6,7-Dimethoxy-3-methyl-1-phenylisoquinoline
(3h)
White crystals, mp 128–129 °C. 1H NMR (DMSO-d6, 400 MHz): δ
7.68 (d, J = 7.2 Hz, 2H), 7.49–7.58 (m, 3H),
7.48 (s, 1H), 7.30 (s, 1H), 7.24 (s, 1H), 3.93 (s, 3H), 3.73 (s, 3H),
2.58 (s, 3H). 13C NMR (DMSO-d6, 100 MHz): δ 156.6, 152.4, 149.2, 148.9, 139.7, 134.1, 129.5
(2C), 129.4, 128.2 (2C), 119.6, 116.8, 104.9, 104.5, 55.6, 55.1, 23.8.
IR (KBr film): 2929, 1620, 1561, 1504, 1456, 1423, 1249, 1218, 1129,
1014, 875, 761, 711 cm–1. HRMS (ESI): calcd for
C18H18NO2 [M + H]+, 280.1338;
found, 280.1334.

4.6.9 1-(3,4-Dimethoxyphenyl)-6,7-dimethoxy-3-methyliso-quinoline
(3i)
White crystals, mp 156–157 °C. 1H NMR (CDCl3, 400 MHz): δ 7.35 (s, 1H), 7.34
(s, 1H), 7.22–7.27 (m, 2H), 7.04 (s, 1H), 7.02 (d, J = 8.2 Hz, 1H), 4.04 (s, 3H), 3.97 (s, 3H), 3.94 (s, 3H),
3.86 (s, 3H), 2.70 (s, 3H). 13C NMR (CDCl3,
100 MHz): δ 157.6, 152.6, 149.6, 149.3, 149.2, 148.9, 134.6,
132.8, 122.2, 120.5, 116.9, 112.9, 111.0, 105.6, 104.4, 56.0, 55.9,
55.8, 42.6, 24.2. IR (KBr film): 2934, 1598, 1562, 1511, 1466, 1424,
1245, 1215, 1142, 1028, 935, 877, 761 cm–1. HRMS
(ESI): calcd for C20H22NO4 [M + H]+, 340.1549; found, 340.1547.

4.6.10 1-Phenylisoquinoline
(3j)
White crystals, mp 95–96 °C. 1H NMR (CDCl3, 400 MHz): δ 8.62 (d, J = 5.7 Hz,
1H), 8.11 (d, J = 8.3 Hz, 1H), 7.88 (d, J = 8.3 Hz, 1H), 7.62–7.73 (m, 4H), 7.47–7.58 (m, 4H). 13C NMR (CDCl3, 100 MHz): δ 160.7, 142.2,
139.6, 136.9, 130.1, 130.0 (2C), 128.6, 128.4 (2C), 127.6, 127.2,
127.0, 126.7, 120.0. IR (KBr film): 2955, 1619, 1583, 1554, 1441,
1383, 1354, 825, 769, 701 cm–1. HRMS (EI): calcd
for C15H11N [M]+, 205.0891; found,
205.0895.

4.6.11 1-(3,4-Dimethoxyphenyl)isoquinoline
(3k)
White crystals, mp 99–100 °C. 1H NMR (CDCl3, 400 MHz): δ 8.59 (d, J = 5.7 Hz, 1H), 8.18 (d, J = 8.2 Hz, 1H),
7.88 (d, J = 8.1 Hz, 1H), 7.70 (dd, J1 = 8.2 Hz, J2 = 8.0 Hz, 1H),
7.63 (d, J = 5.7 Hz, 1H), 7.56 (dd, J1 = 8.1 Hz, J2 = 8.0 Hz, 1H),
7.30 (s, 1H), 7.27 (d, J = 8.2 Hz, 1H), 7.03 (d, J = 8.2 Hz, 1H), 3.98 (s, 3H), 3.95 (s, 3H). 13C NMR (CDCl3, 100 MHz): δ 160.4, 149.6, 149.0, 142.0,
137.0, 132.2, 130.1, 127.7, 127.2, 127.0, 126.8, 122.8, 119.7, 113.1,
110.7, 56.1, 56.0. IR (KBr film): 2962, 2928, 1519, 1463, 1381, 1257,
1244, 1137, 1026, 815 cm–1. HRMS (ESI): calcd for
C17H16NO2 [M + H]+, 266.1181;
found, 266.1180.

4.6.12 1-(4-Chlorophenyl)isoquinoline
(3l)
White crystals, mp 57–58 °C. 1H
NMR (CDCl3, 400 MHz): δ 8.60 (d, J = 5.7 Hz, 1H), 8.05 (d, J = 8.5 Hz, 1H), 7.89 (d, J = 8.2 Hz, 1H), 7.61–7.74 (m, 4H), 7.47–7.58
(m, 3H). 13C NMR (CDCl3, 100 MHz): δ 159.4,
142.1, 137.9, 136.9, 134.8, 131.3 (2C), 130.2, 128.6 (2C), 127.5,
127.2, 127.1, 126.6, 120.3. IR (KBr film): 3046, 2960, 1584, 1550,
1491, 1384, 1354, 1088, 1017, 822, 752 cm–1. HRMS
(ESI): calcd for C15H11NCl [M + H]+, 240.0580; found, 240.0583.

4.6.13 Methyl
6,7-Dimethoxy-1-phenylisoquinoline-3-carboxylate
(3m)
White crystals, mp 172–173 °C. 1H NMR (CDCl3, 400 MHz): δ 8.47 (s, 1H), 7.73
(d, J = 8.2 Hz, 2H), 7.46–7.58 (m, 3H), 7.40
(s, 1H), 7.27 (s, 1H), 4.08 (s, 3H), 4.03 (s, 3H), 3.89 (s, 3H). 13C NMR (CDCl3, 100 MHz): δ 166.8, 158.5,
153.0, 151.7, 139.9, 139.4, 133.3, 129.8 (2C), 128.7, 128.5 (2C),
124.4, 122.1, 106.2, 105.8, 56.2, 56.0, 52.7. IR (KBr film): 2950,
2920, 1707, 1510, 1423, 1279, 1260, 1142, 1011, 707 cm–1. HRMS (ESI): calcd for C19H18NO4 [M + H]+, 324.1236; found, 324.1237.

4.6.14 Methyl 1-(3,4-Dimethoxyphenyl)-6,7-dimethoxyisoquinoline-3-carboxylate
(3n)
White crystals, mp 214–215 °C. 1H NMR (CDCl3, 400 MHz): δ 8.44 (s, 1H), 7.47
(s, 1H), 7.24–7.33 (m, 3H), 7.02 (d, J = 8.5
Hz, 1H), 4.08 (s, 3H), 4.03 (s, 3H), 3.97 (s, 3H), 3.95 (s, 3H), 3.91
(s, 3H). 13C NMR (CDCl3, 100 MHz): δ 166.8,
158.2, 153.0, 151.6, 149.6, 149.0, 139.8, 133.4, 132.1, 124.4, 122.5,
121.8, 113.1, 110.9, 106.3, 106.0, 56.2, 56.1, 56.0 (2C), 52.7. IR
(KBr film): 2958, 2932, 1707, 1512, 1426, 1257, 1167, 1138, 1029,
762 cm–1. HRMS (ESI): calcd for C21H22NO6 [M + H]+, 384.1447; found, 384.1443.

4.6.15 Methyl 1-(Benzo[d][1,3]dioxol-5-yl)-6,7-dimethoxyiso-quinoline-3-carboxylate
(3o)
White crystals, mp 233–234 °C. 1H NMR (CDCl3, 400 MHz): δ 8.45 (s, 1H), 7.45
(s, 1H), 7.28 (s, 1H), 7.23 (d, J = 1.5 Hz, 1H),
7.21 (dd, J1 = 7.9 Hz, J2 = 1.5 Hz, 1H), 6.97 (d, J = 7.9 Hz,
1H), 6.07 (s, 2H), 4.09 (s, 3H), 4.04 (s, 3H), 3.93 (s, 3H). 13C NMR (CDCl3, 100 MHz): δ 166.8, 158.0,
153.0, 151.7, 148.1, 148.0, 139.9, 133.5, 133.4, 124.4, 123.8, 121.9,
110.5, 108.2, 106.3, 105.8, 101.3, 56.2, 56.1, 52.7. IR (KBr film):
2960, 2912, 1707, 1505, 1447, 1425, 1247, 1201, 1158, 1036, 856 cm–1. HRMS (ESI): calcd for C20H18NO6 [M + H]+, 368.1134; found, 368.1136.

4.6.16 Methyl 6,7-Dimethoxy-1-methylisoquinoline-3-carboxylate
(3p)
White crystals, mp 185–186 °C. 1H NMR (CDCl3, 400 MHz): δ 8.30 (s, 1H), 7.28
(s, 1H), 7.14 (s, 1H), 4.04 (s, 3H), 4.02 (s, 3H), 4.00 (s, 3H), 2.95
(s, 3H). 13C NMR (CDCl3, 100 MHz): δ 166.7,
156.4, 153.0, 151.7, 139.4, 132.1, 125.1, 121.9, 106.5, 104.0, 56.2,
56.1, 52.7, 22.7. IR (KBr film): 2951, 1709, 1616, 1510, 1427, 1254,
1219, 1163, 854 cm–1. HRMS (ESI): calcd for C14H16NO4 [M + H]+, 262.1079;
found, 262.1073.

4.6.17 Methyl 6,7-Dimethoxy-1-isopropylisoquinoline-3-carboxylate
(3q)
White crystals, mp 108–109 °C. 1H NMR (CDCl3, 400 MHz): δ 8.34 (s, 1H), 7.53
(s, 1H), 7.26 (s, 1H), 4.08 (s, 3H), 4.06 (s, 3H), 4.03 (s, 3H), 4.02–4.10
(m, 1H), 1.55 (d, J = 6.9 Hz, 6H). 13C
NMR (CDCl3, 100 MHz): δ 167.0, 163.9, 152.5, 151.5,
139.7, 132.7, 123.8, 121.4, 106.8, 103.4, 56.2, 56.1, 52.6, 31.8,
21.8 (2C). IR (KBr film): 2961, 1744, 1707, 1617, 1514, 1428, 1255,
1216, 1154, 1005, 849 cm–1. HRMS (ESI): calcd for
C16H20NO4 [M + H]+, 290.1392;
found, 290.1394.

4.6.18 Methyl 6,7-Dimethoxy-1-(3-(trifluoromethyl)phenyl)iso-quinoline-3-carboxylate
(3r)
White crystals, mp 163–164 °C. 1H NMR (CDCl3, 400 MHz): δ 8.49 (s, 1H), 8.02
(s, 1H), 7.95 (d, J = 7.6 Hz, 1H), 7.77 (d, J = 7.7 Hz, 1H), 7.68 (dd, J1 = 7.6 Hz, J2 = 7.7 Hz, 1H), 7.285 (s,
1H), 7.282 (s, 1H), 4.08 (s, 3H), 4.04 (s, 3H), 3.89 (s, 3H). 13C NMR (CDCl3, 100 MHz): δ 166.6, 156.7,
153.2, 152.1, 140.1, 140.0, 133.5, 133.2, 130.7 (q, 2JCF = 33.2 Hz, 1C), 129.2, 128.9, 126.8 (q, 3JCF = 3.2 Hz, 1C), 125.5 (q, 3JCF = 3.2 Hz, 1C), 124.9 (q, 1JCF = 279.7 Hz, 1C), 122.6, 106.4,
105.1, 56.3, 56.0, 52.8. IR (KBr film): 2952, 1707, 1619, 1509, 1425,
1255, 1166, 1122, 1010, 858 cm–1. HRMS (ESI): calcd
for C20H17F3NO4 [M + H]+, 392.1110; found, 392.1106.

4.6.19 Methyl
1-(2-Chlorophenyl)-6,7-dimethoxyisoquinoline-3-carboxylate
(3s)
White crystals, mp 195–196 °C. 1H NMR (DMSO-d6, 400 MHz): δ
8.57 (s, 1H), 7.74 (s, 1H), 7.68 (d, J = 7.5 Hz,
1H), 7.55–7.62 (m, 3H), 6.76 (s, 1H), 3.97 (s, 3H), 3.90 (s,
3H), 3.71 (s, 3H). 13C NMR (DMSO-d6, 100 MHz): δ 165.7, 155.5, 153.0, 151.9, 139.0, 137.5,
132.5, 132.0, 131.4, 130.5, 129.5, 127.4, 124.2, 122.4, 107.0, 104.2,
56.0, 55.5, 52.2. IR (KBr film): 2952, 1734, 1707, 1507, 1427, 1280,
1256, 1148, 1011, 852, 763 cm–1. HRMS (ESI): calcd
for C19H17ClNO4 [M + H]+, 358.0846; found, 358.0844.

4.6.20 Methyl
6,7-Dimethoxy-1-(2-nitrophenyl)isoquinoline-3-carboxylate
(3t)
White crystals, mp 232–233 °C. 1H NMR (DMSO-d6, 400 MHz): δ
8.56 (s, 1H), 8.26 (d, J = 8.0 Hz, 1H), 7.94 (dd, J1 = 7.8 Hz, J2 =
8.0 Hz, 1H), 7.85 (dd, J1 = 7.8 Hz, J2 = 7.7 Hz, 1H), 7.76 (s, 1H), 7.75 (d, J = 7.7 Hz, 1H), 6.93 (s, 1H), 3.98 (s, 3H), 3.88 (s, 3H),
3.74 (s, 3H). 13C NMR (DMSO-d6, 100 MHz): δ 165.5, 154.4, 153.0, 152.0, 148.8, 138.9, 133.8,
133.4, 132.5, 132.0, 130.3, 124.8, 123.8, 122.4, 107.2, 103.6, 56.0,
55.6, 52.2. IR (KBr film): 2951, 1719, 1615, 1568, 1527, 1508, 1425,
1357, 1257, 1147, 1003, 851, 736 cm–1. HRMS (ESI):
calcd for C19H16N2O6Na
[M + Na]+, 391.0906; found, 391.0904.

4.6.21 Methyl 6,7-Dimethoxy-1-(naphthalen-1-yl)isoquinoline-3-carboxylate
(3u)
White crystals, mp 193–194 °C. 1H NMR (CDCl3, 400 MHz): δ 8.58 (s, 1H), 7.98
(d, J = 7.6 Hz, 1H), 7.93 (d, J =
8.0 Hz, 1H), 7.63 (s, 1H), 7.62 (dd, J1 = 7.6 Hz, J2 = 7.8 Hz, 1H), 7.47 (dd, J1 = 7.8 Hz, J2 =
8.0 Hz, 1H), 7.29–7.41 (m, 3H), 6.82 (s, 1H), 4.07 (s, 3H),
4.01 (s, 3H), 3.57 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 166.8, 158.0, 153.4, 151.8, 140.0, 136.5, 133.7,
133.0, 132.1, 129.1, 128.3, 127.9, 126.3, 126.1, 126.0, 125.9, 125.4,
122.6, 106.1, 106.0, 56.3, 55.9, 52.9. IR (KBr film): 2949, 1737,
1715, 1614, 1507, 1425, 1253, 1205, 1148, 781 cm–1. HRMS (ESI): calcd for C23H20NO4 [M + H]+, 374.1392; found, 374.1391.

4.6.22 Methyl 6,7-Dimethoxy-1-(pyridin-2-yl)isoquinoline-3-carboxylate
(3v)
White crystals, mp 153–154 °C. 1H NMR (CDCl3, 400 MHz): δ 8.77 (d, J = 5.2 Hz, 1H), 8.49 (s, 1H), 8.26 (s, 1H), 8.18 (d, J = 7.8 Hz, 1H), 7.93 (dd, J1 = 7.8 Hz, J2 = 7.5 Hz, 1H), 7.41 (dd, J1 = 7.5 Hz, J2 =
5.2 Hz, 1H), 7.24 (s, 1H), 4.06 (s, 3H), 4.04 (s, 3H), 3.98 (s, 3H). 13C NMR (CDCl3, 100 MHz): δ 166.6, 158.2,
154.6, 153.0, 152.1, 148.2, 139.5, 137.4, 134.0, 125.7, 124.4, 123.5,
123.2, 106.3, 106.1, 56.1, 56.0, 52.7. IR (KBr film): 2948, 1718,
1617, 1588, 1509, 1423, 1254, 1203, 1148, 1110, 1011, 857 cm–1. HRMS (ESI): calcd for C18H17N2O4 [M + H]+, 325.1188; found, 325.1192.

4.6.23 Dimethyl 6,7-Dimethoxyisoquinoline-1,3-dicarboxylate
(3w)
White crystals, mp 180–181 °C. 1H NMR (CDCl3, 400 MHz): δ 8.61 (s, 1H), 8.39
(s, 1H), 7.25 (s, 1H), 4.101 (s, 3H), 4.098 (s, 3H), 4.07 (s, 3H),
4.06 (s, 3H). 13C NMR (CDCl3, 100 MHz): δ
166.2, 165.8, 153.5, 153.3, 144.8, 139.1, 134.3, 125.8, 125.3, 106.0,
104.8, 56.3, 56.2, 53.1, 53.0. IR (KBr film): 2955, 1707, 1617, 1507,
1426, 1260, 1202, 1158, 1120, 1004, 863 cm–1. HRMS
(ESI): calcd for C15H15NO6Na [M +
Na]+, 328.0797; found, 328.0798.

4.6.24 Methyl
6,7-Dimethoxyisoquinoline-1-carboxylate
(3x)
White crystals, mp 62–63 °C. 1H NMR (CDCl3, 400 MHz): δ 8.49 (d, J = 5.4 Hz, 1H), 8.38 (s, 1H), 7.68 (d, J = 5.4 Hz, 1H), 7.08 (s, 1H), 4.07 (s, 3H), 4.05 (s, 3H), 4.03 (s,
3H). 13C NMR (CDCl3, 100 MHz): δ 166.7,
153.0, 151.6, 144.2, 140.6, 134.5, 124.1, 123.3, 104.7, 104.4, 56.1,
56.0, 52.9. IR (KBr film): 2952, 1720, 1618, 1562, 1505, 1483, 1334,
1253, 1146, 994, 865 cm–1. HRMS (ESI): calcd for
C13H14NO4 [M + H]+, 248.0923;
found, 248.0925.

4.6.25 Ethyl 6,7-Dimethoxyisoquinoline-1-carboxylate
(3y)
Pale yellow crystals, mp 50–51 °C. 1H NMR (CDCl3, 400 MHz): δ 8.53 (d, J = 5.4 Hz, 1H), 8.35 (s, 1H), 7.69 (d, J = 5.4 Hz, 1H), 7.11 (s, 1H), 4.57 (q, J = 7.1 Hz,
2H), 4.07 (s, 3H), 4.05 (s, 3H), 1.52 (t, J = 7.1
Hz, 3H). 13C NMR (CDCl3, 100 MHz): δ 166.4,
153.0, 151.4, 145.0, 140.6, 134.4, 123.9, 123.0, 104.7, 104.4, 61.9,
56.1, 56.0, 14.4. IR (KBr film): 2980, 1737, 1621, 1565, 1505, 1482,
1267, 1148, 1015, 865 cm–1. HRMS (ESI): calcd for
C14H16NO4 [M + H]+, 262.1079;
found, 262.1078.

Supporting Information Available
The Supporting
Information is
available free of charge on the ACS Publications website at DOI: 10.1021/acsomega.8b00855.1H
and 13C NMR spectra of isoquinolines 3a–y (PDF)



Supplementary Material
ao8b00855_si_001.pdf

 The authors
declare no competing financial interest.

Acknowledgments
We are grateful to the National Natural Science
Foundation of China (nos. 20972048, 20172015) for the financial support
of this work.
==== Refs
References
a Zhang J. ; Zhang Q.-Y. ; Tu P.-F. ; Xu F.-C. ; Liang H. 
Mucroniferanines
A-G, Isoquinoline Alkaloids from Corydalis mucronifera . J. Nat. Prod. 
2018 , 81 , 364 –370 . 10.1021/acs.jnatprod.7b00847 .29400966  b Aldhaher A. H. S. ; Langat M. K. ; Knirsch W. ; Andriantiana J. L. ; Mulholland D. A. 
Isoquinoline alkaloids from three
Madagascan Crinum (Amaryllidaceae) species . Biochem. Syst. Ecol. 
2018 , 77 , 7 –9 . 10.1016/j.bse.2017.12.008 . c dos Santos A. R. ; Pires C. ; Marques F. A. ; Lobão A. Q. ; Maia B. H. L. N. S. 
Isoquinoline alkaloids isolated from
three Guatteria species . Biochem.
Syst. Ecol. 
2017 , 73 , 1 –2 . 10.1016/j.bse.2017.05.002 . d Iranshahy M. ; Quinn R. J. ; Iranshahi M. 
Biologically
active isoquinoline alkaloids with drug-like properties from the genus
Corydalis . RSC Adv. 
2014 , 4 , 15900 –15913 . 10.1039/c3ra47944g . e Buchanan M. S. ; Davis R. A. ; Duffy S. ; Avery V. M. ; Quinn R. J. 
Antimalarial
Benzylisoquinoline Alkaloid from the Rainforest TreeDoryphora sassafras . J. Nat. Prod. 
2009 , 72 , 1541 –1543 . 10.1021/np9002564 .19637893  f Bentley K.
W. 
β-Phenylethylamines
and the isoquinoline alkaloids . Nat. Prod. Rep. 
2006 , 23 , 444 –463 . 10.1039/b509523a .16741588  g Li G.-Y. ; Li B.-G. ; Yang T. ; Liu G.-Y. ; Zhang G.-L. 
Chaetoindicins
A–C, Three Isoquinoline Alkaloids from the Fungus Chaetomium
Indicum . Org. Lett. 
2006 , 8 , 3613 –3615 . 10.1021/ol061525k .16869673  h Bringmann G. ; Dreyer M. ; Kopff H. ; Rischer H. ; Wohlfarth M. ; Hadi H. A. ; Brun R. ; Meimberg H. ; Heubl G. 
ent-Dioncophylleine
A and Related Dehydrogenated Naphthylisoquinoline Alkaloids, the First
Asian Dioncophyllaceae-Type Alkaloids, from the “New”
Plant Species Ancistrocladus benomensis . J.
Nat. Prod. 
2005 , 68 , 686 –690 . 10.1021/np049626j .15921410  i Carroll A. R. ; Davis R. A. ; Forster P. I. ; Guymer G. P. ; Quinn R. J. 
A Benzylisoquinoline
Alkaloid from Doryphorasassafras . J. Nat. Prod. 
2001 , 64 , 1572 –1573 . 10.1021/np010132l .11754616  j Rashid M. A. ; Gustafson K. R. ; Boyd M. R. 
A New Isoquinoline Alkaloid from
the Marine Sponge Haliclona Species . J. Nat.
Prod. 
2001 , 64 , 1249 –1250 . 10.1021/np0102004 .11575970 
a Kalaiarasi A. ; Anusha C. ; Sankar R. ; Rajasekaran S. ; John Marshal J. ; Muthusamy K. ; Ravikumar V. 
Plant Isoquinoline
Alkaloid Berberine Exhibits Chromatin Remodeling by Modulation of
Histone Deacetylase To Induce Growth Arrest and Apoptosis in the A549
Cell Line . J. Agric. Food Chem. 
2016 , 64 , 9542 –9550 . 10.1021/acs.jafc.6b04453 .27936791  b Yang W. ; Li L. ; Wang Y. ; Wu X. ; Li T. ; Yang N. ; Su M. ; Sheng L. ; Zheng M. ; Zang Y. ; Li J. ; Liu H. 
Design, synthesis and biological evaluation of isoquinoline-based
derivatives as novel histone deacetylase inhibitors . Bioorg. Med. Chem. 
2015 , 23 , 5881 –5890 . 10.1016/j.bmc.2015.06.071 .26211462  c Xu M. ; Wagerle T. ; Long J. K. ; Lahm G. P. ; Barry J. D. ; Smith R. M. 
Insecticidal Quinoline
and Isoquinoline Isoxazolines . Bioorg. Med.
Chem. Lett. 
2014 , 24 , 4026 –4030 . 10.1016/j.bmcl.2014.06.004 .24998379  d Kuo H.-P. ; Chuang T.-C. ; Tsai S.-C. ; Tseng H.-H. ; Hsu S.-C. ; Chen Y.-C. ; Kuo C.-L. ; Kuo Y.-H. ; Liu J.-Y. ; Kao M.-C. 
Berberine, an Isoquinoline Alkaloid,
Inhibits the Metastatic Potential of Breast Cancer Cells via Akt Pathway
Modulation . J. Agric. Food Chem. 
2012 , 60 , 9649 –9658 . 10.1021/jf302832n .22950834  e Wang Y.-X. ; Wang L. ; Xu Y.-N. ; Li Y.-H. ; Jiang J.-D. ; Si S.-Y. ; Li Y.-B. ; Ren G. ; Shan Y.-Q. ; Hong B. ; Song D.-Q. 
Synthesis and structure-activity
relationship of N-(2-arylethyl) isoquinoline derivatives as human
scavenger receptor CD36 antagonists . Eur. J.
Med. Chem. 
2011 , 46 , 1066 –1073 . 10.1016/j.ejmech.2011.01.022 .21295889  f Bhadra K. ; Kumar G. S. 
Therapeutic potential of nucleic
acid-binding isoquinoline alkaloids: Binding aspects and implications
for drug design . Med. Res. Rev. 
2011 , 31 , 821 –862 . 10.1002/med.20202 .20077560  g Ball A. R. ; Casadei G. ; Samosorn S. ; Bremner J. B. ; Ausubel F. M. ; Moy T. I. ; Lewis K. 
Conjugating Berberine to a Multidrug
Resistance Pump Inhibitor Creates an Effective Antimicrobial . ACS Chem. Biol. 
2006 , 1 , 594 –600 . 10.1021/cb600238x .17168555  h Bermejo A. ; Andreu I. ; Suvire F. ; Léonce S. ; Caignard D. H. ; Renard P. ; Pierré A. ; Enriz R. D. ; Cortes D. ; Cabedo N. 
Syntheses and Antitumor
Targeting G1 Phase of the Cell Cycle of Benzoyldihydroisoquinolines
and Related 1-Substituted Isoquinolines . J.
Med. Chem. 
2002 , 45 , 5058 –5068 . 10.1021/jm020831a .12408717  i Jayaraman M. ; Fox B. M. ; Hollingshead M. ; Kohlhagen G. ; Pommier Y. ; Cushman M. 
Synthesis of New Dihydroindeno[1,2-c]isoquinoline and Indenoisoquinolinium Chloride Topoisomerase
I Inhibitors Having High in Vivo Anticancer Activity in the Hollow
Fiber Animal Model . J. Med. Chem. 
2002 , 45 , 242 –249 . 10.1021/jm000498f .11754595  j Lee H.-S. 
Rat Lens
Aldose Reductase Inhibitory Activities ofCoptis japonicaRoot-Derived
Isoquinoline Alkaloids . J. Agric. Food Chem. 
2002 , 50 , 7013 –7016 . 10.1021/jf020674o .12428952 
a Jin Y. ; Makida Y. ; Uchida T. ; Kuwano R. 
Ruthenium-Catalyzed
Chemo- and Enantioselective Hydrogenation of Isoquinoline Carbocycles . J. Org. Chem. 
2018 , 83 , 3829 –3839 . 10.1021/acs.joc.8b00190 .29547282  b Zhang B. ; Huang L. ; Yin S. ; Li X. ; Xu T. ; Zhuang B. ; Wang T. ; Zhang Z. ; Hashmi A. S. K. 
Cascade C=O/C=C/C-N
Bond Formation: Metal-Free Reactions of 1,4-Diynes and 1-En-4-yn-3-ones
with Isoquinoline and Quinoline N-Oxides . Org.
Lett. 
2017 , 19 , 4327 –4330 . 10.1021/acs.orglett.7b01996 .28753297  c Li J.-l. ; Li W.-z. ; Wang Y.-c. ; Ren Q. ; Wang H.-s. ; Pan Y.-m. 
Palladium(ii)-catalyzed C-C and C-O
bond formation for the synthesis of C1-benzoyl isoquinolines from
isoquinoline N-oxides and nitroalkenes . Chem.
Commun. 
2016 , 52 , 10028 –10031 . 10.1039/c6cc03530b . d Xu J.-H. ; Zheng S.-C. ; Zhang J.-W. ; Liu X.-Y. ; Tan B. 
Construction of Tropane Derivatives by the Organocatalytic Asymmetric
Dearomatization of Isoquinolines . Angew. Chem.,
Int. Ed. 
2016 , 55 , 11834 –11839 . 10.1002/anie.201605736 . e Rouchet J.-B. E. Y. ; Schneider C. ; Fruit C. ; Hoarau C. 
Regioselective Decarboxylative Cross-Coupling
of Carboxy Isoquinoline N-Oxides . J. Org. Chem. 
2015 , 80 , 5919 –5927 . 10.1021/acs.joc.5b00475 .25938169  f Zhang J. ; Chen J. ; Zhang X. ; Lei X. 
Total Syntheses of Menisporphine
and Daurioxoisoporphine C Enabled by Photoredox-Catalyzed Direct C-H
Arylation of Isoquinoline with Aryldiazonium Salt . J. Org. Chem. 
2014 , 79 , 10682 –10688 . 10.1021/jo5020432 .25313860  g Zhao D. ; Glorius F. 
Enantioselective Hydrogenation
of Isoquinolines . Angew. Chem., Int. Ed. 
2013 , 52 , 9616 –9618 . 10.1002/anie.201304756 . h Shang Y. ; Wang L. ; He X. ; Zhang M. 
Novel syntheses of
pyrrolo[2,1-a]isoquinolines via 1,3-dipolar cycloaddition
between Isoquinoliniums and alkynes . RSC Adv. 
2012 , 2 , 7681 –7688 . 10.1039/c2ra21116e . i Yadav J. S. ; Reddy B. V. S. ; Gupta M. K. ; Prabhakar A. ; Jagadeesh B. 
First example of ring expansion of activated quinolines
and isoquinolines: novel benzoazepines . Chem.
Commun. 
2004 , 2124 –2125 . 10.1039/b405100a .
a Sun L. ; Li D. ; Zhou X. ; Zhang D. ; Wang J. ; He Z. ; Jiang R. ; Chen W. 
General and
Catalytic Enantioselective Approach to Isopavine Alkaloids . J. Org. Chem. 
2017 , 82 , 12899 –12907 . 10.1021/acs.joc.7b02385 .29083182  b He Q. ; Xie F. ; Fu G. ; Quan M. ; Shen C. ; Yang G. ; Gridnev I. D. ; Zhang W. 
Palladium-Catalyzed Asymmetric Addition of Arylboronic Acids to Nitrostyrenes . Org. Lett. 
2015 , 17 , 2250 –2253 . 10.1021/acs.orglett.5b00863 .25879921  c Malkov A. V. ; Ramírez-López P. ; Biedermannová L. ; Rulíšek L. ; Dufková L. ; Kotora M. ; Zhu F. ; Kočovský P. 
On the Mechanism
of Asymmetric Allylation of Aldehydes with Allyltrichlorosilanes Catalyzed
by QUINOX, a Chiral IsoquinolineN-Oxide . J.
Am. Chem. Soc. 
2008 , 130 , 5341 –5348 . 10.1021/ja711338q .18341275  d Taylor A. M. ; Schreiber S. L. 
Enantioselective Addition of Terminal
Alkynes to Isolated Isoquinoline Iminiums . Org.
Lett. 
2006 , 8 , 143 –146 . 10.1021/ol0526165 .16381588  e Koradin C. ; Polborn K. ; Knochel P. 
Enantioselective Synthesis
of Propargylamines by Copper-Catalyzed Addition of Alkynes to Enamines . Angew. Chem., Int. Ed. 
2002 , 41 , 2535 –2538 . 10.1002/1521-3773(20020715)41:14<2535::aid-anie2535>3.0.co;2-m . f Lim C. W. ; Tissot O. ; Mattison A. ; Hooper M. W. ; Brown J. M. ; Cowley A. R. ; Hulmes D. I. ; Blacker A. J. 
Practical
Preparation and Resolution of 1-(2’-Diphenylphosphino-1’-naphthyl)isoquinoline:
A Useful Ligand for Catalytic Asymmetric Synthesis . Org. Process Res. Dev. 
2003 , 7 , 379 –384 . 10.1021/op034007n .
a Li G. ; Li P. ; Zhuang X. ; Ye K. ; Liu Y. ; Wang Y. 
Rational Design and Characterization
of Heteroleptic
Phosphorescent Complexes for Highly Efficient Deep-Red Organic Light-Emitting
Devices . ACS Appl. Mater. Interfaces 
2017 , 9 , 11749 –11758 . 10.1021/acsami.7b00348 .28293941  b Caillé F. ; Bonnet C. S. ; Buron F. ; Villette S. ; Helm L. ; Petoud S. ; Suzenet F. ; Tóth É. 
Isoquinoline-Based
Lanthanide Complexes: Bright NIR Optical Probes and Efficient MRI
Agents . Inorg. Chem. 
2012 , 51 , 2522 –2532 . 10.1021/ic202446e .22233349  c Chahine J. ; Saffon N. ; Cantuel M. ; Fery-Forgues S. 
Spontaneous
Formation of Fluorescent Nanofibers and Reticulated Solid from Berberine
Palmitate: A New Example of Aggregation-Induced Emission Enhancement
in Organic Ion Pairs . Langmuir 
2011 , 27 , 2844 –2853 . 10.1021/la104302d .21338124  d Halimani M. ; Chandran S. P. ; Kashyap S. ; Jadhav V. M. ; Prasad B. L. V. ; Hotha S. ; Maiti S. 
Dendritic Effect of Ligand-Coated
Nanoparticles: Enhanced Apoptotic Activity of Silica–Berberine
Nanoconjugates . Langmuir 
2009 , 25 , 2339 –2347 . 10.1021/la802761b .19146398  e Mikata Y. ; Yamanaka A. ; Yamashita A. ; Yano S. 
Isoquinoline-Based
TQEN Family as TPEN-Derived Fluorescent Zinc Sensors . Inorg. Chem. 
2008 , 47 , 7295 –7301 . 10.1021/ic8002614 .18642899  f Deiters E. ; Song B. ; Chauvin A.-S. ; Vandevyver C. D. B. ; Gumy F. ; Bünzli J.-C. G. 
Luminescent Bimetallic Lanthanide
Bioprobes for Cellular Imaging with Excitation in the Visible-Light
Range . Chem.—Eur. J. 
2009 , 15 , 885 –900 . 10.1002/chem.200801868 .19065695 
a Yao T. ; Liu T. ; Zhang C. 
Palladium-catalyzed
domino Heck/intermolecular cross-coupling: efficient synthesis of
4-alkylated isoquinoline derivatives . Chem.
Commun. 
2017 , 53 , 2386 –2389 . 10.1039/c6cc10075a . b Feng S. ; Li T. ; Du C. ; Chen P. ; Song D. ; Li J. ; Xie X. ; She X. 
Visible-light-mediated
radical insertion/cyclization cascade reaction: synthesis of phenanthridines
and isoquinolines from isocyanides . Chem. Commun. 
2017 , 53 , 4585 –4588 . 10.1039/c7cc01813d . c Wen L.-R. ; Dou Q. ; Wang Y.-C. ; Zhang J.-W. ; Guo W.-S. ; Li M. 
Synthesis
of 1-Thio-Substituted Isoquinoline Derivatives by Tandem Cyclization
of Isothiocyanates . J. Org. Chem. 
2017 , 82 , 1428 –1436 . 10.1021/acs.joc.6b02605 .28090769  d Jiang Y. ; Sun R. ; Wang Q. ; Tang X.-Y. ; Shi M. 
Cyclization of sulfide,
ether or tertiary amine-tethered N-sulfonyl-1,2,3-triazoles: a facile
synthetic protocol for 3-substituted isoquinolines or dihydroisoquinolines . Chem. Commun. 
2015 , 51 , 16968 –16971 . 10.1039/c5cc07511d . e Coppola A. ; Sucunza D. ; Burgos C. ; Vaquero J. J. 
Isoquinoline Synthesis by Heterocyclization of Tosylmethyl
Isocyanide Derivatives: Total Synthesis of Mansouramycin B . Org. Lett. 
2015 , 17 , 78 –81 . 10.1021/ol5032624 .25521281  f Shekarrao K. ; Kaishap P. P. ; Gogoi S. ; Boruah R. C. 
Efficient
synthesis of isoquinolines and pyridines via copper(I)-catalyzed multi-component
reaction . RSC Adv. 
2014 , 4 , 14013 –14023 . 10.1039/c3ra46722h . g Jiang H. ; Cheng Y. ; Wang R. ; Zhang Y. ; Yu S. 
Synthesis
of isoquinolines via visible light-promoted insertion of vinyl isocyanides
with diaryliodonium salts . Chem. Commun. 
2014 , 50 , 6164 –6167 . 10.1039/c4cc01122h . h Pilgrim B. S. ; Gatland A. E. ; McTernan C. T. ; Procopiou P. A. ; Donohoe T. J. 
Modular Isoquinoline Synthesis Using Catalytic Enolate
Arylation and in Situ Functionalization . Org. Lett. 
2013 , 15 , 6190 –6193 . 10.1021/ol4030309 .24251885  i Si C. ; Myers A. G. 
A Versatile Synthesis of Substituted
Isoquinolines . Angew. Chem., Int. Ed. 
2011 , 50 , 10409 –10413 . 10.1002/anie.201104769 . j Guimond N. ; Fagnou K. 
Isoquinoline Synthesis via Rhodium-Catalyzed Oxidative
Cross-Coupling/Cyclization of Aryl Aldimines and Alkynes . J. Am. Chem. Soc. 
2009 , 131 , 12050 –12051 . 10.1021/ja904380q .19705909  k Fischer D. ; Tomeba H. ; Pahadi N. K. ; Patil N. T. ; Huo Z. ; Yamamoto Y. 
Iodine-Mediated Electrophilic
Cyclization of 2-Alkynyl-1-methylene Azide Aromatics Leading to Highly
Substituted Isoquinolines and Its Application to the Synthesis of
Norchelerythrine . J. Am. Chem. Soc. 
2008 , 130 , 15720 –15725 . 10.1021/ja805326f .18942781  l Niu Y.-N. ; Yan Z.-Y. ; Gao G.-L. ; Wang H.-L. ; Shu X.-Z. ; Ji K.-G. ; Liang Y.-M. 
Synthesis of Isoquinoline Derivatives
via Ag- Catalyzed Cyclization of 2-Alkynyl Benzyl Azides . J. Org. Chem. 
2009 , 74 , 2893 –2896 . 10.1021/jo900010m .19271738 
a Cox E. D. ; Cook J. M. 
The Pictet-Spengler Condensation:
A New Direction for an Old Reaction . Chem. Rev. 
1995 , 95 , 1797 –1842 . 10.1021/cr00038a004 . b Stöckigt J. ; Antonchick A. P. ; Wu F. ; Waldmann H. 
The Pictet-Spengler
Reaction in Nature and in Organic Chemistry . Angew. Chem., Int. Ed. 
2011 , 50 , 8538 –8564 . 10.1002/anie.201008071 .
a Bischler A. ; Napieralski B. 
Zur Kenntniss einer neuen Isochinolinsynthese . Ber. Dtsch. Chem. Ges. 
1893 , 26 , 1903 –1908 . 10.1002/cber.189302602143 .b Whaley W. M. ; Govindachari T. R.  Preparation
of 3,4-dihydro-isoquinolines and related compounds by Bischler-Napieralski
reaction . In Organic Reactions ; Adams R.  , Ed.; John Wiley
and Sons : New York , 1951 ; Vol. VI , p 74 . c Judeh Z. M. A. ; Ching C. B. ; Bu J. ; McCluskey A. 
The first
Bischler-Napieralski cyclization in a room temperature ionic liquid . Tetrahedron Lett. 
2002 , 43 , 5089 –5091 . 10.1016/s0040-4039(02)00998-x .
a Wang Q. ; Chai H. ; Yu Z. 
Acceptorless Dehydrogenation
of N-Heterocycles and Secondary Alcohols by Ru(II)-NNC Complexes Bearing
a Pyrazoyl-indolyl-pyridine Ligand . Organometallics 
2018 , 37 , 584 –591 . 10.1021/acs.organomet.7b00902 . b Kato S. ; Saga Y. ; Kojima M. ; Fuse H. ; Matsunaga S. ; Fukatsu A. ; Kondo M. ; Masaoka S. ; Kanai M. 
Hybrid Catalysis Enabling Room-Temperature Hydrogen Gas Release from N-Heterocycles and Tetrahydronaphthalenes . J. Am. Chem. Soc. 
2017 , 139 , 2204 –2207 . 10.1021/jacs.7b00253 .28139917  c Wu J. ; Talwar D. ; Johnston S. ; Yan M. ; Xiao J. 
Acceptorless Dehydrogenation of Nitrogen Heterocycles
with a Versatile Iridium Catalyst . Angew. Chem.,
Int. Ed. 
2013 , 52 , 6983 –6987 . 10.1002/anie.201300292 . d Ge D. ; Hu L. ; Wang J. ; Li X. ; Qi F. ; Lu J. ; Cao X. ; Gu H. 
Reversible Hydrogenation-Oxidative
Dehydrogenation of Quinolines over a Highly Active Pt Nanowire Catalyst
under Mild Conditions . ChemCatChem 
2013 , 5 , 2183 –2186 . 10.1002/cctc.201300136 . e Muthaiah S. ; Hong S. H. 
Acceptorless and Base-Free Dehydrogenation of Alcohols
and Amines using Ruthenium-Hydride Complexes . Adv. Synth. Catal. 
2012 , 354 , 3045 –3053 . 10.1002/adsc.201200532 . f Buchstaller H.-P. ; Burgdorf L. ; Finsinger D. ; Stieber F. ; Sirrenberg C. ; Amendt C. ; Grell M. ; Zenke F. ; Krier M. 
Design and synthesis of isoquinolines
and benzimidazoles as RAF kinase inhibitors . Bioorg. Med. Chem. Lett. 
2011 , 21 , 2264 –2269 . 10.1016/j.bmcl.2011.02.108 .21420298  g Iwasa K. ; Moriyasu M. ; Tachibana Y. ; Kim H.-S. ; Wataya Y. ; Wiegrebe W. ; Bastow K. F. ; Cosentino L. M. ; Kozuka M. ; Lee K.-H. 
Simple
Isoquinoline and Benzylisoquinoline Alkaloids as Potential Antimicrobial,
Antimalarial, Cytotoxic, and Anti-HIV Agents . Bioorg. Med. Chem. 
2001 , 9 , 2871 –2884 . 10.1016/s0968-0896(01)00154-7 .11597468  h Pelletier J. C. ; Cava M. P. 
Synthesis of the Marine Alkaloids
Aaptamine and Demethyloxyaaptamine and of the Parent Structure Didemethoxyaaptamine . J. Org. Chem. 
1987 , 52 , 616 –622 . 10.1021/jo00380a024 .
a Gao F. ; Liu H. ; Li L. ; Guo J. ; Wang Y. ; Zhao M. ; Peng S. 
Design, synthesis,
and testing of an isoquinoline-3-carboxylic-based novel anti-tumor
lead . Bioorg. Med. Chem. Lett. 
2015 , 25 , 4434 –4436 . 10.1016/j.bmcl.2015.09.014 .26386603  b Zheng M. ; Yang Y. ; Zhao M. ; Zhang X. ; Wu J. ; Chen G. ; Peng L. ; Wang Y. ; Peng S. 
A class of
novel N-isoquinoline-3-carbonyl-L-amino acid benzylesters: Synthesis, anti-tumor evaluation and 3D
QSAR analysis . Eur. J. Med. Chem. 
2011 , 46 , 1672 –1681 . 10.1016/j.ejmech.2011.02.017 .21414693 
a Nicolaou K.
C. ; Mathison C. J. N. ; Montagnon T. 
o-Iodoxybenzoic Acid (IBX) as a Viable
Reagent in the Manipulation
of Nitrogen- and Sulfur-Containing Substrates: Scope, Generality,
and Mechanism of IBX-Mediated Amine Oxidations and Dithiane Deprotections . J. Am. Chem. Soc. 
2004 , 126 , 5192 –5201 . 10.1021/ja0400382 .15099102  b Nicolaou K.
C. ; Mathison C. J. N. ; Montagnon T. 
New Reactions of IBX: Oxidation of Nitrogen- and Sulfur-Containing
Substrates To Afford Useful Synthetic Intermediates . Angew. Chem., Int. Ed. 
2003 , 42 , 4077 –4082 . 10.1002/anie.200352076 .
Sanz R. ; Fernández Y. ; Castroviejo M. P. ; Pérez A. ; Fañanás F. J. 
Functionalized Phenanthridine and
Dibenzopyranone Derivatives through Benzyne Cyclization - Application
to the Total Syntheses of Trisphaeridine andN-Methylcrinasiadine . Eur. J. Org. Chem. 
2007 , 62 –69 . 10.1002/ejoc.200600621 .
a Gutteridge C. E. ; Hoffman M. M. ; Bhattacharjee A. K. ; Milhous W. K. ; Gerena L. 
In vitro efficacy of
7-benzylamino-1-isoquinolinamines
against Plasmodium falciparum related to the efficacy of chalcones . Bioorg. Med. Chem. Lett. 
2011 , 21 , 786 –789 . 10.1016/j.bmcl.2010.11.099 .21168330  b Gutteridge C. E. ; Hoffman M. M. ; Bhattacharjee A. K. ; Gerena L. 
Synthesis and Antimalarial Activity of 7-Benzylamino-1-Isoquinolinamines . J. Heterocycl. Chem. 
2007 , 44 , 633 –637 . 10.1002/jhet.5570440319 .
Murashige R. ; Ohtsuka Y. ; Sagisawa K. ; Shiraishi M. 
Versatile
synthesis of 3,4-dihydroisoquinolin-1(2 H )-one derivatives via intra-molecular
Friedel-Crafts reaction with trifluoromethanesulfonic acid . Tetrahedron Lett. 
2015 , 56 , 3410 –3412 . 10.1016/j.tetlet.2015.01.168 .
Karki M. ; Araujo H. C. ; Magolan J. 
Dehydroaromatization with V2O5 . Synlett 
2013 , 24 , 1675 –1678 . 10.1055/s-0033-1339277 .
a Kendall J. D. ; Rewcastle G. W. ; Frederick R. ; Mawson C. ; Denny W. A. ; Marshall E. S. ; Baguley B. C. ; Chaussade C. ; Jackson S. P. ; Shepherd P. R. 
Synthesis,
biological evaluation and molecular modelling of sulfonohydrazides
as selective PI3K p110α inhibitors . Bioorg.
Med. Chem. 
2007 , 15 , 7677 –7687 . 10.1016/j.bmc.2007.08.062 .17869522  b Shi J. ; Manolikakes G. ; Yeh C.-H. ; Guerrero C. A. ; Shenvi R. A. ; Shigehisa H. ; Baran P. S. 
Scalable Synthesis
of Cortistatin A and Related Structures . J.
Am. Chem. Soc. 
2011 , 133 , 8014 –8027 . 10.1021/ja202103e .21539314 
a Liu M.-C. ; Lin T.-S. ; Penketh P. ; Sartorelli A. C. 
Synthesis and Antitumor Activity of 4- and 5-Substituted
Derivatives of Isoquinoline-1-carboxaldehyde Thiosemicarbazone . J. Med. Chem. 
1995 , 38 , 4234 –4243 . 10.1021/jm00021a012 .7473550  b Martinez S.
J. ; Larsen L. ; Street J. D. ; Joule J. A. 
Synthesis of 6-Hydroxy-1,4-dimethylisoquinoline
and of Ethyl 7-Hydroxy-6-methoxy-1-methylisoquinoline-3-carboxylate . J. Chem. Soc., Perkin Trans. 1 
1988 , 1705 –1710 . 10.1039/p19880001705 . c Agrawal K. C. ; Mooney P. D. ; Sartorelli A. C. 
Potential
Antitumor Agents. 13. 4-Methyl-5-amino-1-formylisoquinoline Thiosemicarbazone . J. Med. Chem. 
1976 , 19 , 970 –972 . 10.1021/jm00229a023 .940117 
a McCann S. D. ; Stahl S. S. 
Copper-Catalyzed
Aerobic Oxidations of Organic Molecules: Pathways for Two-Electron
Oxidation with a Four-Electron Oxidant and a One-Electron Redox-Active
Catalyst . Acc. Chem. Res. 
2015 , 48 , 1756 –1766 . 10.1021/acs.accounts.5b00060 .26020118  b Guo X.-X. ; Gu D.-W. ; Wu Z. ; Zhang W. 
Copper-Catalyzed
C-H Functionalization Reactions: Efficient Synthesis of Heterocycles . Chem. Rev. 
2015 , 115 , 1622 –1651 . 10.1021/cr500410y .25531056  c Allen S. E. ; Walvoord R. R. ; Padilla-Salinas R. ; Kozlowski M. C. 
Aerobic Copper-Catalyzed Organic Reactions . Chem. Rev. 
2013 , 113 , 6234 –6458 . 10.1021/cr300527g .23786461  d Wendlandt A. E. ; Suess A. M. ; Stahl S. S. 
Copper-Catalyzed
Aerobic Oxidative C-H Functionalizations: Trends and Mechanistic Insights . Angew. Chem., Int. Ed. 
2011 , 50 , 11062 –11087 . 10.1002/anie.201103945 . e Zhang C. ; Tang C. ; Jiao N. 
Recent advances in copper-catalyzed dehydrogenative functionalization via a single electron transfer (SET) process . Chem. Soc. Rev. 
2012 , 41 , 3464 –3484 . 10.1039/c2cs15323h .22349590 
a Patil R. D. ; Adimurthy S. 
Copper-Catalyzed
Aerobic Oxidation of Amines to Imines under Neat Conditions with Low
Catalyst Loading . Adv. Synth. Catal. 
2011 , 353 , 1695 –1700 . 10.1002/adsc.201100100 . b Patil R. D. ; Adimurthy S. 
Copper(0)-catalyzed aerobic oxidative
synthesis of imines from amines under solvent-free conditions . RSC Adv. 
2012 , 2 , 5119 –5122 . 10.1039/c2ra20339a .
a Clark R. A. ; Parker D. C. 
Imine-Enamine Tautomerism.
I. 2-(N-Cyclohexylimino)-1,3-diphenylpropane . J. Am. Chem. Soc. 
1971 , 93 , 7257 –7261 . 10.1021/ja00755a022 . b Eisch J. J. ; Gadek F. J. 
Nonpyridinoid azaaromatic
systems. I. Synthesis and tautomeric character of cyclopenta[b]quinoline
(benzo[b][1]pyrindine) . J. Org. Chem. 
1971 , 36 , 2065 –2071 . 10.1021/jo00814a008 .
Coşkun N. ; Tunçman S. 
Synthesis of stable azomethine ylides
by the rearrangement
of 1,3-dipolar cycloadducts of 3,4-dihydroisoquinoline-2-oxides with
DMAD . Tetrahedron 
2006 , 62 , 1345 –1350 . 10.1016/j.tet.2005.11.040 .
a Lee C.-S. ; Yu T.-C. ; Luo J.-W. ; Cheng Y.-Y. ; Chuang C.-P. 
Radical-initiated cyclization as
a key step for the synthesis of oxoprotoberberine alkaloids . Tetrahedron Lett. 
2009 , 50 , 4558 –4562 . 10.1016/j.tetlet.2009.05.095 . b Xie J.-H. ; Yan P.-C. ; Zhang Q.-Q. ; Yuan K.-X. ; Zhou Q.-L. 
Asymmetric Hydrogenation of Cyclic
Imines Catalyzed by Chiral Spiro Iridium Phosphoramidite Complexes
for Enantioselective Synthesis of Tetrahydroisoquinolines . ACS Catal. 
2012 , 2 , 561 –564 . 10.1021/cs300069g .

